Elevate your research with our cutting-edge In Vitro Research Tools that are available on Fisher Scientific. Our high-quality, innovative Bio-Spun™ scaffolds are designed to enhance precision, efficiency, and reproducibility across various scientific applications. Shop now to advance your discoveries with ease. https://lnkd.in/dxTqApWp #InnovateInVitro #ResearchRevolution #PrecisionScience #AdvanceYourResearch #ReproducibleResults
BioSurfaces, LLC’s Post
More Relevant Posts
-
On-demand Webinar: Accelerate the Use of iPSC-derived Organoids in Drug Discovery & Personal Medicine. An excellent opportunity to gain insights into a novel approach that addresses the limitations faced by current organoid workflows. Webinar Recording Link: https://hubs.ly/Q02nzwBR0 Presented by Allysa Stern, Ph.D., Scientist II, Product Applications at Cell Microsystems, this session delves into challenges within existing workflows, offering solutions to inefficiency, labor-intensive processes, and limitations in heterogeneity and throughput. #iPSCorganoids #DrugDiscovery #CellRaftTechnology
To view or add a comment, sign in
-
Certified QSP I Driving Innovation in Medical Devices & Healthcare Solutions I CMU Dual Master's Graduate
My colleague, Margaret (Mache) Cruz, presented our research on "Facile Extraction of α2 Beta Casein Milk-Derived Extracellular Vesicles and Their Impact on C2C12 Cell Migration" at BMES. This research highlights how milk-derived EVs can enhance cell migration in C2C12 murine myoblasts, showcasing their potential in therapeutic applications for tissue healing. We are proud of our team's dedication to advancing biomedical engineering. #BiomedicalEngineering #ResearchInnovation #ExtracellularVesicles #TissueEngineering #CMUEngineering
To view or add a comment, sign in
-
Understanding molecular variation in the brain is key for our understanding of neurological disorders, yet current methods miss the mark. This case study highlights Jonathon Mill and team’s multiomic approach using #nanopore technology to characterise both epigenetic and transcriptional variation in the brain. It shares how nanopore technology enabled the characterisation and quantification of thousands of novel isoform transcripts (including 11 linked to Alzheimer’s disease), the identification of millions of CpG sites as well as the detection of DNA modification 5-hydroxymethylcytosine — a modification critical in regulating alternative splicing in neurons, but hard to differentiate using alternative methods1. Find out more: https://bit.ly/4gja3eX
To view or add a comment, sign in
-
🔬 Nikon Instruments debuts AX R with NSPARC 2K software for biotechnology research AX R with NSPARC 2K software is designed to offer maximum resolution performance across four times the field of view. It is the latest addition to Nikon’s AX series lineup. The enhanced functionalities of the AX R equipped with the NSPARC Super-Resolution Confocal Microscope is said to accelerate the speed and efficiency of experiments in fundamental biology, disease research, and drug development. The Nikon Spatial Array Confocal (NSPARC) detector, integrated with the AX R Confocal Microscope system, facilitates more accurate observations with minimal noise and sharp image contrast. Read more online: https://lnkd.in/e4WA-QTg 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing
To view or add a comment, sign in
-
Ph.D. Candidate in Biomedical Engineering, Duke University | Incoming Postdoctoral Fellow at New York Stem Cell Foundation, Diabetes (2025)
Check out our most recent publication (my 2nd 1st-authored research article) in Science Advances demonstrating tissue-specific morphogenesis in a hiPS cell-derived kidney-on-a-chip model. https://lnkd.in/etS3bXr4 In this study, we showed that utilizing an ultrathin biomimetic membrane in an organ-on-a-chip device, hiPS cell-derived generic vascular endothelial cells were spontaneously induced into more specialized fenestrated endothelial cells in situ, in the presence of podocytes, through VEGF signaling. This work is listed as the featured paper in the 07 JUN 2024 issue. #scienceadvances #organonachip #musahlab #dukeuniversity
To view or add a comment, sign in
-
Cellsonics is excited to bring you this webinar featuring David Ferrick, PhD and CEO of Cellsonics. Sourcing abundant, high quality ex-vivo single cells, whether for cell sorting, single cell RNA-Seq, or cell outgrowth like organoids, is a crucial step in single cell workflows. Despite its importance, innovation in tissue dissociation has lagged, with current workflows remaining complex and dissociation conditions often harsh on the single cells of interest. In this webinar David will introduce the SimpleFlow System which performs non-enzymatic tissue dissociation. The SimpleFlow System utilizes acoustic energy to isolate single cells from complex tissues. This method offers a rapid alternative to intricate mechanical or harsh enzymatic dissociation techniques, preserving a high yield of live cells and more accurately maintaining the native tissue's heterogeneity. https://lnkd.in/emXf8KVx
To view or add a comment, sign in
-
Have you already seen our latest blog post?
Serum-free cryopreservation is revolutionizing cell-based research across the board — from tissue engineering to drug discovery. In our blog post, we discuss the broad applicability of these advanced solutions, ensuring optimal viability and functionality of cell populations. Interested in learning more about how to maximize the potential of your cell cultures with serum-free cryomedia? Read our blog post: https://lnkd.in/eduVeJVJ
To view or add a comment, sign in
-
🚨 Happy to share my first work accepted at NeurIPS MLSB workshop: "Systems-Structure-Based Drug Design." Building on previous insights into the connection between systems and structural biology. https://lnkd.in/gGqXQiyN We are able to identify probable protein-protein binding sites. Once identified, we perform an evolutionary analysis to identify "hot spots" for probable orthosteric small molecule binding sites that interrupt BMP ligand-receptor interactions. Once the "hot spot" is identified for both the target of interest and competing pocket(s), we use the Bio-Diffusion small molecule generation diffusion model to create new small molecules of varying sizes for the pocket. We guide the generation with DiffDock-Pocket confidence model of the predicted denoised small molecule fit to the "hot spot" of interest. Problem: this isn't differentiable. Solution: simple gradient approximation and checkpointing. The former is self explanatory but the latter was a revelation that you could take the best prediction out of a sample in the generation process and that would help guide the small molecule generation. We applied this method to the Bone Morphogenetic Protein (BMP) pathway for two complexes of interest and, for three different sizes of molecules, were able to generate small molecules that were more specific to the "hot spot" of interest. The confidence of DiffDock methods isn't the same as binding affinity so we checked the binding affinity for one small molecule using AutoDock Vina and found the confidences correlated with worse/better binding affinity! (n=1, though) Come visit the poster & chat at the NeurIPS MLSB 2024 workshop in Vancouver if you're interested in learning more. #drugdiscovery #bayesian #diffusion
Systems-Structure-Based Drug Design
arxiv.org
To view or add a comment, sign in
-
I highly recommend this webinar to all interested in drug discovery and development!
🌐 Upcoming Webinar: Moving compounds to IND using predictive retina models 🌐 Our expert panelists will share their insights from Regulatory, Technology, and Scientific Perspectives. They will also delve into strategies for streamlining the clinical development pipeline, with a special focus on retina-related compounds. 🔬Speakers: Dr Lauren E. Black - Distinguished Scientist/Consultant, working mainly at the first in human (FIH) stage - in high-risk diseases using novel products at Charles River Laboratories Dr Roxana Redis - Associate Science Director, leading the development of the ASO hit to lead platform within Early Discovery at Charles River Laboratories Dr Valeria Chichagova, PhD - Associate Director of iPSC Technology/ Head of Retina, leading the development and commercialization of the Newcells retinal platform at Newcells Biotech. 📅 June 19th ⏰2:00 PM BST 🔗 Secure your spot now. Find out more and register here: https://lnkd.in/eEZqXdEj #Newcells #VisionResearch #Retina
To view or add a comment, sign in
-
🤔 Did you know that using a different mixing platform can change the morphology of your drug product? 👩🔬 We designed a study in conjunction with Phosphorex in order to demonstrate how #cryoTEM analysis compares to techniques like DLS and Ribogreen assay. We compared four #lipidnanoparticle formulations and saw surprising differences in morphology. 🔬 Cryo-TEM imaging reveals unique details about nanoparticle formulations that cannot be revealed with other methods. 📩 Download the whitepaper to see the results: https://lnkd.in/gia_uTZc
To view or add a comment, sign in
1,034 followers